Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.

Valentin LeducqKaren ZafilazaAntoine FauchoisEmna GhidaouiSophie SayonCéline DorivalMarie-Laure MeledjeClovis Lusivika-NzingaYouri YordanovGuillaume Martin-BlondelFabrice CarratAnne-Geneviève MarcelinCathia Soulienull null

Published in: The Journal of infectious diseases (2023)

In conclusion, the probability of emerging mutations arising in response to mAbs is significant, emphasizing the crucial need to investigate these mutations thoroughly and assess their impact on patients and the evolutionary trajectory of the SARS-CoV-2.

Keyphrases

sars cov
end stage renal disease
newly diagnosed
chronic kidney disease
coronavirus disease
genome wide
respiratory syndrome coronavirus
protein protein
rare case